Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy A Teft

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Immunology Letters|July 19, 2008
Characterization of oligomers induced by inverse agonists of CTLA-4Wendy A Teft, Joaquín Madrenas
Current Opinion in Investigational Drugs (London, England : 2000)|November 23, 2006
The immunological synapse as a novel therapeutic targetWendy A Teft, Joaquin Madrenas
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2007
Molecular determinants of inverse agonist activity of biologicals targeting CTLA-4Wendy A Teft, Joaquín Madrenas
Pharmacogenomics|October 4, 2013
Sunny outlook for personalized medicine: tamoxifen and beyondWendy A Teft, Richard B Kim
BMC Immunology|May 2, 2009
Structure-Function analysis of the CTLA-4 interaction with PP2AWendy A Teft, Thu A Chau, Joaquín Madrenas
Annual Review of Immunology|March 23, 2006
A molecular perspective of CTLA-4 functionWendy A Teft, Mark G Kirchhof, Joaquín Madrenas
Genome|August 12, 2005
Tarsus determination in Drosophila melanogasterAnthony Percival-Smith, Wendy A Teft, Jodi Lynn Barta
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 15, 2010
Endoxifen, the active metabolite of tamoxifen, is a substrate of the efflux transporter P-glycoprotein (multidrug resistance 1)Wendy A Teft, Sara E Mansell, Richard B Kim
BMC Cancer|May 13, 2016
Profound reduction in tamoxifen active metabolite endoxifen in a breast cancer patient treated with rifampin prior to initiation of an anti-TNFα biologic for ulcerative colitis: a case reportSara L Henderson, Wendy A Teft, Richard B Kim
Pharmacogenetics and Genomics|June 11, 2014
Profound reduction in the tamoxifen active metabolite endoxifen in a patient on phenytoin for epilepsy compared with a CYP2D6 genotype matched cohortSteven E Gryn, Wendy A Teft, Richard B Kim
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Immunology Letters|July 19, 2008
Characterization of oligomers induced by inverse agonists of CTLA-4Wendy A Teft, Joaquín Madrenas
Current Opinion in Investigational Drugs (London, England : 2000)|November 23, 2006
The immunological synapse as a novel therapeutic targetWendy A Teft, Joaquin Madrenas
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2007
Molecular determinants of inverse agonist activity of biologicals targeting CTLA-4Wendy A Teft, Joaquín Madrenas
Pharmacogenomics|October 4, 2013
Sunny outlook for personalized medicine: tamoxifen and beyondWendy A Teft, Richard B Kim
BMC Immunology|May 2, 2009
Structure-Function analysis of the CTLA-4 interaction with PP2AWendy A Teft, Thu A Chau, Joaquín Madrenas
Annual Review of Immunology|March 23, 2006
A molecular perspective of CTLA-4 functionWendy A Teft, Mark G Kirchhof, Joaquín Madrenas
Genome|August 12, 2005
Tarsus determination in Drosophila melanogasterAnthony Percival-Smith, Wendy A Teft, Jodi Lynn Barta
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 15, 2010
Endoxifen, the active metabolite of tamoxifen, is a substrate of the efflux transporter P-glycoprotein (multidrug resistance 1)Wendy A Teft, Sara E Mansell, Richard B Kim
BMC Cancer|May 13, 2016
Profound reduction in tamoxifen active metabolite endoxifen in a breast cancer patient treated with rifampin prior to initiation of an anti-TNFα biologic for ulcerative colitis: a case reportSara L Henderson, Wendy A Teft, Richard B Kim
Pharmacogenetics and Genomics|June 11, 2014
Profound reduction in the tamoxifen active metabolite endoxifen in a patient on phenytoin for epilepsy compared with a CYP2D6 genotype matched cohortSteven E Gryn, Wendy A Teft, Richard B Kim
Pageof 3